🎲 The Oddsmaker 25% Downside Club

Ten Stocks Where Expectations Appear Larger Than The Current Business

Investors often focus on what a company could become.

Markets ultimately focus on what a company earns.

The largest stock drawdowns rarely occur because investors identify bad businesses. They occur because investors pay prices that already discount extraordinary future success.

This screen started with a simple requirement:

Wall Street analyst downside of at least 25%.

We then layered in:

  • Enterprise Value

  • TEV/Revenue

  • Operating Cash Flow

  • Stock-Based Compensation

  • Cash Conversion Cycle

  • Recent price momentum

The result is a list of companies where future expectations appear substantially larger than current operating performance.

Top 10 Downside Candidates

Rank

Ticker

Analyst Downside

Risk Score

1

NVTS

-50.6%

10.0

2

FCEL

-67.0%

9.8

3

ASTS

-38.2%

9.7

4

AXTI

-37.7%

9.5

5

AEHR

-33.0%

9.4

6

WOLF

-36.8%

9.2

7

ENPH

-38.1%

8.8

8

AGL

-29.2%

8.6

9

MXL

-39.4%

8.5

10

MRAM

-46.6%

8.2

1. Navitas Semiconductor (NVTS)

The Numbers

Metric

Value

Enterprise Value

$6.4B

TEV/Revenue

159x

Q1 2026 Revenue

$8.6M

Operating Cash Burn (Q1)

$16.4M

Cash Balance

$221M

Navitas generated just $8.6 million of revenue during Q1 2026 while consuming $16.4 million of operating cash. Revenue remains well below prior-year levels despite recent enthusiasm surrounding AI power infrastructure.

Valuation Math

At an 8x sales multiple:

Required Revenue = $800M

Current Annualized Revenue = ~$34M

Revenue Expansion Required = ~24x

Odds

Scenario

Price Outcome

Probability

Bear

-75%

50%

Base

-50%

35%

Bull

+50%

15%

2. FuelCell Energy (FCEL)

The Numbers

Metric

Value

Enterprise Value

$1.2B

Analyst Downside

-67%

Operating Cash Flow

-$114M

Cash Conversion Cycle

357 Days

Unlike most companies on this list, FuelCell's challenge is not primarily valuation.

It is economics.

Annual cash consumption represents nearly 10% of enterprise value.

Odds

Scenario

Price Outcome

Probability

Bear

-80%

55%

Base

-60%

35%

Bull

+40%

10%

3. AST SpaceMobile (ASTS)

The Numbers

Metric

Value

Enterprise Value

~$40B

Analyst Downside

-38%

Q1 Revenue

$14.7M

Q1 Net Loss

$191M

Revenue Guidance

$150M-$200M

AST generated $14.7 million of Q1 revenue while reporting a $191 million quarterly loss. Revenue missed analyst expectations by a substantial margin.

Recent launch delays and satellite deployment setbacks have increased execution risk while maintaining a valuation that assumes large-scale commercial adoption.

Valuation Math

At 10x revenue:

Required Revenue = $4.0B

Management's 2026 revenue guidance:

$150M-$200M

The valuation implies revenue eventually exceeding current guidance by roughly 20x.

Odds

Scenario

Price Outcome

Probability

Bear

-70%

40%

Base

-35%

40%

Bull

+150%

20%

4. AXT (AXTI)

The Numbers

Metric

Value

Enterprise Value

$7.4B

TEV/Revenue

77x

Analyst Downside

-37.7%

Cash Conversion Cycle

459 Days

Valuation Math

At 8x sales:

Required Revenue = $925M

The market currently values AXT as though it will become dramatically larger than its current operating footprint.

Odds

Scenario

Price Outcome

Probability

Bear

-70%

45%

Base

-40%

35%

Bull

+80%

20%

5. Aehr Test Systems (AEHR)

The Numbers

Metric

Value

Enterprise Value

$3.1B

TEV/Revenue

69x

Analyst Downside

-33%

Cash Conversion Cycle

616 Days

Valuation Math

At 10x sales:

Required Revenue = $312M

Investors are effectively pricing years of continued silicon carbide demand growth.

Odds

Scenario

Price Outcome

Probability

Bear

-65%

40%

Base

-35%

40%

Bull

+60%

20%

The Most Important Observation

The common characteristic across this list is not poor technology.

Most of these companies operate in attractive industries:

  • AI Infrastructure

  • Satellite Communications

  • Hydrogen

  • Silicon Carbide

  • Power Electronics

The common characteristic is valuation.

Many trade at enterprise values that imply revenue growth of 10x–25x before investors earn an attractive return.

History suggests that when expectations become this elevated, future stock performance becomes increasingly dependent on flawless execution.

The Oddsmaker takeaway is simple:

The higher the expectations, the smaller the margin for error.

And in investing, margin for error is often the most important metric of all.

6. Wolfspeed (WOLF)

The Numbers

Metric

Value

Enterprise Value

$3.8B

TEV/Revenue

5.4x

Analyst Downside

-36.8%

Operating Cash Flow

-$391M

Cash Conversion Cycle

189 Days

1-Month Return

+152%

What Matters

Unlike NVTS or AEHR, Wolfspeed's problem is not revenue multiple expansion.

The problem is capital intensity.

The company has spent billions building silicon carbide manufacturing capacity while demand growth has fallen short of prior expectations.

Valuation Math

Current valuation assumes:

  • Silicon carbide EV adoption accelerates

  • Capacity utilization improves materially

  • Significant margin expansion

  • Capital requirements moderate

The challenge is that negative operating cash flow remains extremely large relative to enterprise value.

Odds

Scenario

Price Outcome

Probability

Bear

-70%

45%

Base

-40%

35%

Bull

+100%

20%

7. Enphase Energy (ENPH)

The Numbers

Metric

Value

Enterprise Value

$8.8B

TEV/Revenue

6.3x

Analyst Downside

-38.1%

Operating Cash Flow

$191M

Stock-Based Compensation

$207M

Cash Conversion Cycle

139 Days

What Matters

Enphase is one of the few names on this list generating meaningful operating cash flow.

This is not a business quality short thesis.

This is a valuation and demand normalization thesis.

Valuation Math

The company currently trades closer to historical peak multiples despite:

  • slower residential solar demand

  • elevated interest rates

  • softer installation activity

The market continues to assume a return to prior growth rates.

Odds

Scenario

Price Outcome

Probability

Bear

-50%

35%

Base

-25%

45%

Bull

+50%

20%

8. agilon health (AGL)

The Numbers

Metric

Value

Enterprise Value

$1.3B

TEV/Revenue

0.23x

Analyst Downside

-29.2%

Operating Cash Flow

-$50M

Stock-Based Compensation

$39M

1-Month Return

+224%

What Matters

This is one of the most interesting stocks on the screen.

Unlike most names on this list, valuation appears inexpensive.

However, investors are paying for a turnaround.

Valuation Math

The key question is not revenue.

The key question is profitability.

The market is assuming:

  • improved physician economics

  • lower medical cost trends

  • margin stabilization

Failure to execute could lead to renewed pressure despite the low revenue multiple.

Odds

Scenario

Price Outcome

Probability

Bear

-60%

40%

Base

-30%

40%

Bull

+30%

20%

9. MaxLinear (MXL)

The Numbers

Metric

Value

Enterprise Value

$8.8B

TEV/Revenue

17.4x

Analyst Downside

-39.4%

Operating Cash Flow

$22M

Stock-Based Compensation

$74M

1-Month Return

+88%

What Matters

MaxLinear screens as expensive relative to current semiconductor fundamentals.

Revenue growth remains muted while valuation has expanded significantly.

Valuation Math

At 8x revenue:

Required Revenue = ~$1.1B

Current valuation implies substantial future growth despite limited current operating momentum.

Odds

Scenario

Price Outcome

Probability

Bear

-50%

35%

Base

-30%

45%

Bull

+40%

20%

10. Everspin Technologies (MRAM)

The Numbers

Metric

Value

Enterprise Value

$696M

TEV/Revenue

12.2x

Analyst Downside

-46.6%

Operating Cash Flow

$9M

Stock-Based Compensation

$5.5M

Cash Conversion Cycle

146 Days

What Matters

MRAM is arguably the highest-quality business among the names on this screen.

The company:

  • generates cash flow

  • has a differentiated memory technology

  • maintains a stronger balance sheet

The downside argument is primarily valuation-driven.

Valuation Math

The market is discounting:

  • rapid adoption of MRAM technology

  • substantial future design wins

  • continued market share gains

Any slowdown in adoption could compress the multiple significantly.

Odds

Scenario

Price Outcome

Probability

Bear

-50%

35%

Base

-25%

45%

Bull

+60%

20%

Oddsmaker Summary Table

Ticker

TEV/Revenue

Analyst Downside

OCF ($M)

Risk Score

NVTS

159x

-50.6%

-46

10.0

AXTI

77x

-37.7%

N/A

9.5

AEHR

69x

-33.0%

-7

9.4

MXL

17x

-39.4%

22

8.5

MRAM

12x

-46.6%

9

8.2

ASTS

NM

-38.2%

-91

9.7

FCEL

7x

-67.0%

-114

9.8

ENPH

6x

-38.1%

191

8.8

WOLF

5x

-36.8%

-391

9.2

AGL

0.2x

-29.2%

-50

8.6

Highest Conviction Ideas

Tier 1 (Best Risk/Reward)

  1. NVTS

  2. ASTS

  3. FCEL

  4. AEHR

  5. WOLF

These five names combine:

  • Significant analyst downside

  • Weak cash flow profiles

  • Elevated expectations

  • Valuation assumptions that require extraordinary future execution

The common thread is not bad technology.

The common thread is that current enterprise values appear to discount outcomes that are materially larger than today's operating businesses.

Reply

Avatar

or to participate

Keep Reading